Where is InvivoGen located?

InvivoGen is headquartered in San Diego, United States. It is registered at San Diego, California.

How many employees does InvivoGen have?

As of Dec 31, 2024, the latest employee count at InvivoGen is 17.

Is InvivoGen a funded company?

InvivoGen is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does InvivoGen rank among its competitors?

InvivoGen ranks 249th amongst 803 active competitors, of which 67 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was RoosterBio, which secured $12M in Mar, 2024.

Who are the top competitors of InvivoGen?

InvivoGen's top competitors include Abcam, BioLife Solutions and Meridian Bioscience. Among them, RoosterBio secured the most recent funding round in March, 2024.

InvivoGen - 2026 Company Profile, Team & Competitors

Company Details

Reagents and tools for cell biology research, innate immunity focus. The company provides high-quality reagents and tools for life scientists, specializing in innate immunity and cell culture. They offer a wide range of products, including PRR ligands, cell lines, selective antibiotics, antimicrobial agents, vaccine adjuvants, antibodies, proteins, cloning and expression vectors, and genes and promoters. The company also provides custom services such as cell line development, cloning, and PRR compound screening. Their products support research in areas like PRR signaling, inflammasomes, regulated cell death, immunotherapy, vaccination, autophagy, antibody engineering, cytokines, and COVID-19. They offer resources like newsletters, guides, reviews, educational content, flyers, posters, pathways, and videos. The website includes features like a cart, login, quick order, and country selection.

Website: www.invivogen.com/
Social
Registered Address: San Diego, California

Key Metrics

Founded Year

1997

Location

San Diego, United States

Stage

Unfunded

Ranked

249^th among 803 active competitors

Employee Count

17 as on Dec 31, 2024

Similar Companies

Abcam & 968 more

View InvivoGen's full profile

InvivoGen is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Invivogen CIN: 330781872 , United States, Active	Dec 26, 999	-	17 (As on Dec 31, 2024)	-

InvivoGen has not raised any funding rounds yet.

The founders of InvivoGen is Gerard Tiraby.

Here are the details of InvivoGen's key team members:

Gerard Tiraby: Founder of InvivoGen.

View details of InvivoGen's Founder profiles and Board Members

InvivoGen's employee count trend

InvivoGen has 17 employees as of Dec 24. Here is InvivoGen's employee count trend over the years:

Uncover InvivoGen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of InvivoGen include Abcam, BioLife Solutions and Meridian Bioscience. Here is the list of Top 10 competitors of InvivoGen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	BioLife Solutions 1987, Bothell (United States), Public	Developer of cell and gene therapies with the integrity of a single cell	-	-	68/100
3rd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	NIH, JobsOhio	65/100
4th	RoosterBio 2012, Frederick (United States), Series B	Developer of human mesenchymal stem cells and extracellular vesicles	$38.4M	Planetary Technologies, Dynamk Capital & 4 others	64/100
5th	Integrated DNA Technologies 1987, Coralville (United States), Acquired	Provider of oligonucleotide-based reagents and kits	-	Summit Partners, Golub Capital & 1 others	61/100
6th	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	60/100
7th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
8th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Telegraph Hill Partners, Europa	58/100
9th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 4 others	55/100
10th	Cayman Chem 1980, Ann Arbor (United States), Funding Raised	Develops bioreagents and offers preclinical services	-	Broadoak Capital Partners & 3 others	53/100
249th	InvivoGen 1997, San Diego (United States), Unfunded	Reagents and tools for cell biology research, innate immunity focus	-	-	28/100